Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 3 Insider Initial Statement of Ownership
  2. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 70,000 shares (option exercise)
  5. 4 Exercise or conversion VP, CFO, Treasurer, Secretary acquired 22,657 shares (option exercise)
  6. 4 Open-market sale 10% owner sold 1,354,632 shares at an average $3.26 ($4,411,696)
  7. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  8. 4 Exercise or conversion President and CEO acquired 100,000 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 270,500 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 483,733 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 130,000 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 237,500 shares (option exercise)
  13. 4 Exercise or conversion VP, CFO, Treasurer, Secretary acquired 53,689 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 110,004 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 120,000 shares (option exercise)
  16. 4 Exercise or conversion President and CEO acquired 110,000 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 34 · 675 filings